Significance of serum APE1-AAbs, PTX-3, and miR-486-3p in patients with colorectal cancer undergoing radical surgery

doi:10.4251/wjgo.v17.i5.105192

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1325)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

HTML

555

Figures (1-3)

182

Tables (1-6)

192

Sum=988

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

227

Sum=290

May 15, 2025 (publication date) through Aug 13, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. May 15, 2025; 17(5): 105192
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105192

Full Size Figure Download Figure

Figure 3 Receiver operating characteristic curves of apurinic/apyrimidinic endonuclease 1 autoantibodies, peripheral pentraxin-3, and miR-486-3p levels alone and their combination for predicting postoperative recurrence and metastasis of colorectal cancer. APE1-AAbs: Apurinic/apyrimidinic endonuclease 1 autoantibodies; PTX-3: Peripheral pentraxin-3.

Citation: Wang H, Wang W. Significance of serum APE1-AAbs, PTX-3, and miR-486-3p in patients with colorectal cancer undergoing radical surgery. World J Gastrointest Oncol 2025; 17(5): 105192
URL: https://www.wjgnet.com/1948-5204/full/v17/i5/105192.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.105192